Discover 644 paid clinical trials in Milwaukee, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 644
Active & Responsive
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus
Location: 108 recruiting locations
Sponsor: AbbVie
Sex: All
Age: 18 - 63
Code: NCT05843643
Phase3, Recruiting
Active & Responsive
Perception of Speech in Context by Listeners With Healthy and Impaired Hearing
for
Hearing, Hearing Loss
Location: 2 recruiting locations
Sponsor: Marquette University
Sex: All
Age: 18 - 65
Code: NCT06465979
Recruiting
Active & Responsive
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
for
Genetic Disease
Location: 18 recruiting locations
Sponsor: National Human Genome Research Institute (NHGRI)
Sex: All
Age: 0 - 70+
Code: NCT02450851
Recruiting
Active & Responsive
Computer-guided Action Planning to Support Physical Activity (CAPPA) for Employees with Chronic Knee Symptoms
for
Osteoarthritis of Knee, Knee Pain Chronic
Location: 1 recruiting location
Sponsor: Marquette University
Sex: All
Age: 18+
Code: NCT06734052
Recruiting
Active & Responsive
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: 15 recruiting locations
Sponsor: Caribou Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05722418
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants With Hearing Loss Due to Otoferlin Mutations
for
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF),
Location: 9 recruiting locations
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 0 - 17
Code: NCT05788536
Phase1, Phase2, Recruiting
Active & Responsive
A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation
for
AML, Myelodysplastic Syndromes, ALL, Adult
Location: 14 recruiting locations
Sponsor: TScan Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05473910
Phase1, Recruiting
Active & Responsive
Gastroschisis Outcomes of Delivery (GOOD) Study
for
Gastroschisis
Location: 32 recruiting locations
Sponsor: Medical College of Wisconsin
Sex: Female
Age: 18+
Code: NCT02774746
Recruiting
Active & Responsive
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy